SCHEMBL12311337

SCHEMBL12311337

CC(=O)N1CCN(CCNc2ccccc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 3/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.53
▸ GAA P10253 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ ALOX12 P18054 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ GFER P55789 1/20 0.52
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HTR7 P34969 2/20 0.49
▸ CARM1 Q86X55 1/20 0.48
▸ PRMT6 Q96LA8 1/20 0.48
▸ LMNA P02545 1/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ FAAH O00519 1/20 0.47
▸ POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311352 0.87 ALDH1A1 (0.56) KDM1ANPSR1GAAMAPTALOX15
SCHEMBL7737516 0.83 HTR7 (0.58) KDM1ANPSR1MAPTHTR7CARM1
SCHEMBL5815112 0.82 ALDH1A1 (0.51) KDM1ANPSR1SMN1; SMN2HTR7LMNA
SCHEMBL12311274 0.81 ACKR3 (0.56) NPSR1MAPTMAPK1HTTPKM
SCHEMBL9799141 0.81 MAPT (0.57) GAAMAPTALOX15ALOX12MAPK1
SCHEMBL5027731 0.79 CACNA2D1 (0.57) KMT2AMEN1CYP2C9CYP2C19
SCHEMBL11566590 0.79 CA12 (0.47) KDM1ANPSR1HTTSMN1; SMN2HTR7
SCHEMBL3862105 0.78 HTR7 (0.43) KDM1ANPSR1HTTSMN1; SMN2HTR7
SCHEMBL4932045 0.77 DPP7 (0.58) KDM1AMAPTHTR7CARM1PRMT6
SCHEMBL24581225 0.76 HRH3 (0.70) KDM1ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022059-B2 Indazole acrylic acid amide compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-20 — — US disclosed
US-8022059-B2 Indazole acrylic acid amide compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-20 — — US disclosed
US-20100256108-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-10-07 — — US disclosed
US-20100256108-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-10-07 — — US disclosed
EP-2192116-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2010-06-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256108-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND KCNH2, KCNH3, KCNJ11 KDM1A 608/4885NPSR1 564/4885GAA 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback